Novel Therapies for Essential Tremor

This study has been completed.
Sponsor:
Information provided by:
Department of Veterans Affairs
ClinicalTrials.gov Identifier:
NCT00018564
First received: July 3, 2001
Last updated: January 20, 2009
Last verified: December 2004
  Purpose

This clinical research program is designed to evaluate medications as new treatments for essential tremor. Essential tremor is a common condition with few available therapies.


Condition Intervention Phase
Essential Tremor
Drug: treatments for essential tremor
Phase 3

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Masking: Double-Blind
Primary Purpose: Treatment
Official Title: Novel Therapies for Essential Tremor

Resource links provided by NLM:


Further study details as provided by Department of Veterans Affairs:

Study Start Date: October 2000
Estimated Study Completion Date: September 2003
Detailed Description:

Each medication will be evaluated for effectiveness against tremor in a randomized, placebo-controlled, cross-over, double blind clinical research trial. Tremor will be assessed with accepted rating scales and accelerometry

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria
  1. Diagnosis of essential tremor.
  2. Tremor rating scale score 3 or one or both upper extremities
  3. Unsatisfactory response to primidone or to propanolol
  4. Not taking tremor-inducing drug
  5. Able to comply with visits
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00018564

Locations
United States, California
VA Greater Los Angeles Healthcare System
Los Angeles, California, United States, 90073
Sponsors and Collaborators
Investigators
Investigator: Fredricka Martin, Ph.D.
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00018564     History of Changes
Other Study ID Numbers: NEUD-048-00S
Study First Received: July 3, 2001
Last Updated: January 20, 2009
Health Authority: United States: Federal Government

Additional relevant MeSH terms:
Tremor
Essential Tremor
Dyskinesias
Neurologic Manifestations
Nervous System Diseases
Signs and Symptoms
Movement Disorders
Central Nervous System Diseases

ClinicalTrials.gov processed this record on April 17, 2014